Procurement notices · Find a Tender + Contracts Finder

Notices

Every UK public-sector procurement notice in one board — open opportunities, closed tenders, awards, and pre-market signals. Filter by deadline, value or CPV, and save your search as an alert.

Closing 24h

Open notices

Closing this week

Don’t miss

Open · all

70,824

Live opportunities

Posted · 24h

247

New notices

Posted · 30d

8,181

All notice types

Awarded · 7d

1,066

Market signal

ActiveView: Closed Clear all

165,209 noticesclosed · sorted by publication date

Page 205 of 8261

Time to close

Value

Type

Buyer

Notice

CLOSED

20 Feb

—

Estimated

Closed

DEPARTMENT FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS

Testing Object-Oriented Nudges for Regulatory Compliance in Environmental Land

Business services· Published 29 May

Notice peek

ClosedCF · 113f430021cb

SCI Cleanroom Cleaning 2025/26

NHS Blood & Transplant (NHSBT)

Status

Closed

Estimated

£350k

Published

09 Dec 2025

Key facts

Notice ID: cf-b567c383-e23e-498e-858b-113f430021cb
CPV code: 90910000 · Sewage & refuse
Source: Contracts Finder

Timeline

Published
09 Dec 2025

Description

The Cellular and Molecular Therapies (CMT) function is a Specialist Services department forming part of NHS Blood and Transplant (NHSBT) Therapeutic Services. The laboratories process, store and distribute human cell based products and gene therapies for transplantation and other therapies. CMT consists of seven laboratories based within NHSBT facilities at Barnsley, Birmingham, Filton (Bristol), Liverpool, Oxford and Southampton. Currently, these laboratories require scheduled and adhoc deep cleans of their clean rooms, with frequencies detailed in Appendix 1. Each laboratory operates clean room facilities in accordance with EUGMP (Annex 1) requirements and is licensed by the Human Tissue Authority (HTA) in accordance with the Human Tissue (Quality and Safety for Human Application) Regulations 2007 and the Joint Accreditation Committee - ISCT and EBMT (JACIE). The activities of the NHSBT CMT stem cell processing laboratories involve processing, testing, storage and distribution of human progenitor cells for autologous and/or allogeneic transplantation. Liverpool, Barnsley, CBC, Birmingham and Filton laboratories are also regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) for cell and gene therapy medicinal product manufacture. A high level of hygiene and cleanliness is essential to preventing contamination and maintaining the sterility of these products.